Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.46
0.04 (0.28%)
At close: Aug 15, 2025, 3:59 PM
14.08
-2.66%
After-hours: Aug 15, 2025, 05:42 PM EDT
Keros Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 18.17M | 211.25M | 3.04M | 388K | 37K | 83K | 143K | 8K | n/a | n/a | n/a | n/a | 100K | n/a | 20M | n/a | 100K | n/a |
Cost of Revenue | 370K | 344K | 332K | 314K | 306K | 277K | 247K | 551K | 545K | 689K | 448K | 337K | 514K | 316K | 302K | 223K | 9.98M | 179K |
Gross Profit | 17.8M | 211.25M | 2.71M | 74K | -269K | -194K | -104K | -543K | -545K | -689K | -448K | -337K | -414K | -316K | 19.7M | -223K | -9.88M | -179K |
Operating Income | -39.82M | 152.04M | -53.25M | -58.66M | -50.44M | -48.48M | -46.45M | -43.28M | -41.34M | -38.87M | -31.96M | -27.98M | -30.73M | -24.13M | -4.87M | -20.2M | -15.54M | -15.77M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -32.92M | 158.49M | -45.73M | -52.96M | -45.26M | -43.11M | -40.24M | -39.44M | -37.51M | -35.8M | -29.72M | -23.51M | -27.27M | -24.19M | -4.94M | -20.34M | -15.62M | -15.84M |
Net Income | -30.7M | 148.45M | -46.03M | -52.96M | -45.26M | -43.11M | -40.24M | -39.44M | -37.51M | -32.74M | -29.72M | -19.04M | -23.8M | -24.19M | -6.94M | -20.3M | -15.62M | -15.88M |
Selling & General & Admin | 14.48M | 10.5M | 10.66M | 9.82M | 9.65M | 10.31M | 9.11M | 9.15M | 8.8M | 7.78M | 7.09M | 6.94M | 7.45M | 6.05M | 6.03M | 5.37M | 5.66M | 4.27M |
Research & Development | 43.5M | 48.71M | 45.63M | 49.23M | 40.52M | 38.26M | 37.49M | 34.14M | 32.53M | 31.09M | 24.87M | 21.04M | 23.28M | 18.08M | 18.83M | 14.83M | 9.98M | 11.49M |
Other Expenses | -370K | n/a | -332K | -314K | -196K | -437K | -10.94M | 3.84M | 3.83M | 3.06M | 2.24M | -3.71M | -3.38M | -59K | -74K | -137K | -80K | -65K |
Operating Expenses | 57.62M | 59.21M | 55.96M | 58.73M | 50.17M | 48.57M | 44.2M | 43.29M | 41.34M | 38.87M | 31.96M | 24.27M | 27.35M | 24.13M | 24.87M | 20.2M | 15.64M | 15.77M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | 1K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -306K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 57.98M | 59.21M | 56.3M | 59.05M | 50.48M | 48.57M | 44.2M | 43.29M | 41.34M | 38.87M | 31.96M | 24.27M | 27.35M | 24.13M | 24.87M | 20.2M | 15.64M | 15.77M |
Income Tax Expense | -2.22M | 10.04M | 300K | n/a | n/a | -277K | n/a | -210K | n/a | -3.06M | 2K | -4.47M | -3.46M | 1K | 2M | -38K | -79K | 50K |
Shares Outstanding (Basic) | 40.61M | 40.56M | 40.34M | 36.1M | 36.1M | 29.45M | 30.13M | 29.67M | 29.6M | 28.37M | 27.33M | 25.55M | 24.05M | 23.99M | 23.44M | 23.36M | 23.31M | 23.23M |
Shares Outstanding (Diluted) | 40.61M | 41.02M | 40.34M | 36.1M | 36.1M | 29.45M | 30.13M | 29.67M | 29.6M | 28.37M | 27.33M | 25.55M | 24.05M | 23.99M | 23.44M | 23.36M | 23.31M | 23.23M |
EPS (Basic) | -0.76 | 3.66 | -1.14 | -1.47 | -1.25 | -1.46 | -1.34 | -1.33 | -1.27 | -1.15 | -1.09 | -0.75 | -0.99 | -1.01 | -0.3 | -0.87 | -0.67 | -0.68 |
EPS (Diluted) | -0.76 | 3.62 | -1.14 | -1.47 | -1.25 | -1.46 | -1.34 | -1.33 | -1.27 | -1.15 | -1.09 | -0.75 | -0.99 | -1.01 | -0.3 | -0.87 | -0.67 | -0.68 |
EBITDA | -39.82M | 152.38M | -29.14M | -58.34M | -50.13M | -48.21M | -40M | -43.07M | -41.15M | -38.87M | -29.27M | -20.2M | -30.13M | -24.07M | -4.64M | -20.2M | -15.43M | -15.77M |
EBIT | -32.92M | 152.04M | -29.47M | -58.66M | -50.44M | -48.48M | -40.24M | -43.28M | -41.34M | -38.87M | -29.72M | -23.51M | -27.27M | -24.18M | -4.94M | -20.33M | -15.62M | -15.83M |
Depreciation & Amortization | 370K | 344K | 332K | 314K | 306K | 277K | 247K | 551K | 545K | 689K | 448K | 337K | 514K | 316K | 302K | 223K | 194K | 179K |